Psyence Biomedical (PBM) Payables (2023 - 2025)
Psyence Biomedical (PBM) recorded quarterly Payables of $261937.0 in Q1 2025, down 53.42% quarter-over-quarter from $562352.0 in Q1 2024, and down 53.42% on a YoY basis from $562352.0 in Q1 2024.
Psyence Biomedical (PBM) Payables (2023 - 2025) Analysis & Trends
Psyence Biomedical's Payables history runs 3 years deep, the most recent figure standing at $261937.0 for Q1 2025.
- In Q1 2025, Payables fell 53.42% year-over-year to $261937.0; the TTM figure through Mar 2025 stood at $261937.0 (down 53.42% YoY), while the FY2025 annual figure was $261937.0, down 53.42% from the prior year.
- Payables was $261937.0 for Q1 2025 at Psyence Biomedical, down from $562352.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $1.8 million in Q1 2023 to a low of $261937.0 in Q1 2025.
- Historically, Payables has averaged $871663.0 across 3 years, with a median of $562352.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Payables sank 68.6% in 2024, then slumped 53.42% in 2025.
- A 3-year view of Payables shows it stood at $1.8 million in 2023, then tumbled by 68.6% to $562352.0 in 2024, then plunged by 53.42% to $261937.0 in 2025.
- The last three Payables figures came in at $261937.0 (Q1 2025), $562352.0 (Q1 2024), and $1.8 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 34.55 Mn |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 261,937.00 |
| Mar 31, 2024 | 562,352.00 |
| Mar 31, 2023 | 1.79 Mn |